CIK 0001649094
- Large accelerated filer
Vaxcyte, Inc.
Sign in to watch- Ticker
- PCVX
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 464233385
- Phone
- +1 650-837-0111
- Business address
- 825 INDUSTRIAL ROAD, STE. 300, SAN CARLOS, CA, 94070
- Former names
- SutroVax, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $5,185,988
- in 8 filings, $4.8M under 10b5-1 plans
Net −$5,185,988. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 88 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-05-05 | Fairman Jeff VP, Research | Sale | −888 | $25.80 | $23K | 325,339 |
| 2022-04-22 | Sauer Paul SVP Process Dev, Manufacturing | Sale | −3,000 | $25.00 | $75K | 25,125 |
| 2022-04-18 | Wassil Jim Chief Operating Officer | Exercise or conversion | +2,800 | $2.42 | $7K | 45,744 |
| 2022-04-18 | Wassil Jim Chief Operating Officer | Sale | −2,800 | $23.98 | $67K | 42,944 |
| 2022-04-18 | Wassil Jim Chief Operating Officer | Exercise or conversion · Stock Option (right to buy) | −2,800 | 233,126 | ||
| 2022-04-18 | GUGGENHIME ANDREW President and CFO | Exercise or conversion | +3,100 | $5.35 | $17K | 43,725 |
| 2022-04-18 | GUGGENHIME ANDREW President and CFO | Sale | −3,100 | $24.05 | $75K | 40,625 |
| 2022-04-18 | GUGGENHIME ANDREW President and CFO | Exercise or conversion · Stock Option (right to buy) | −3,100 | 506,018 | ||
| 2022-04-18 | PICKERING GRANT Chief Executive Officer | Exercise or conversion | +11,000 | $1.79 | $20K | 714,894 |
| 2022-04-18 | PICKERING GRANT Chief Executive Officer | Sale | −11,000 | $23.98 | $264K | 703,894 |
| 2022-04-18 | PICKERING GRANT Chief Executive Officer | Exercise or conversion · Stock Option (right to buy) | −11,000 | 245,450 | ||
| 2022-04-05 | Fairman Jeff VP, Research | Sale | −5,000 | $25.59 | $128K | 326,227 |
| 2022-03-22 | Sauer Paul SVP Process Dev, Manufacturing | Sale | −3,000 | $25.00 | $75K | 28,125 |
| 2022-03-22 | PICKERING GRANT Chief Executive Officer | Exercise or conversion | +7,712 | $1.79 | $14K | 711,606 |
| 2022-03-22 | PICKERING GRANT Chief Executive Officer | Sale | −7,712 | $24.62 | $190K | 703,894 |
| 2022-03-22 | PICKERING GRANT Chief Executive Officer | Exercise or conversion · Stock Option (right to buy) | −7,712 | 256,450 | ||
| 2022-03-21 | PICKERING GRANT Chief Executive Officer | Exercise or conversion | +14,288 | $1.79 | $26K | 718,182 |
| 2022-03-21 | PICKERING GRANT Chief Executive Officer | Sale | −13,929 | $24.92 | $347K | 704,253 |
| 2022-03-21 | PICKERING GRANT Chief Executive Officer | Sale | −359 | $25.68 | $9K | 703,894 |
| 2022-03-21 | PICKERING GRANT Chief Executive Officer | Exercise or conversion · Stock Option (right to buy) | −14,288 | 264,162 |
Page 49 of 51 · 1,004 trades